Moreover, TLR4 has been involved in its impact on PTX resistance causing the increase of pro-inflammatory cytokines and their receptors to favor cancer aggressiveness and chemoresistance in ovarian cancers [9–12]. Here, TLR4 is linked to ovarian carcinoma.